Text Size
674 studies found for:    Attention Deficit-Hyperactivity Disorder

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
Attention Deficit-Hyperactivity Disorder (674 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Active, not recruiting Efficacy & Safety of KAPVAY™ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: KAPVAY™ (clonidine hydrochloride);   Drug: Placebo
2 Completed Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity;   Attention Deficit Hyperactivity Disorders
Intervention: Drug: NRP104
3 Completed An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Drug: methylphenidate hydrochloride
4 Completed
Has Results 		A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Atomoxetine Hydrochloride;   Drug: Placebo
5 Completed
Has Results 		Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: CLONICEL (Clonidine HCl sustained release)
6 Completed
Has Results 		An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity;   Attention Deficit Hyperactivity Disorders
Intervention: Drug: Vyvanse (lisdexamfetamine dimesylate), NRP104
7 Not yet recruiting Effect of Methylphenidate on Connectivity
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Methylphenidate;   Other: Placebo
8 Enrolling by invitation Improving the Medication Management of Patients With Attention-Deficit Hyperactivity Disorder
Condition: Attention Deficit-hyperactivity Disorder
Intervention: Behavioral: Clinical decision support for medication titration
9 Completed Pilot Study of Duloxetine in Adult Attention Deficit Hyperactivity Disorder(ADHD)
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: duloxetine;   Drug: placebo
10 Terminated
Has Results 		Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE
Conditions: Attention Deficit Hyperactivity Disorder;   Cannabis Abuse
Intervention: Drug: Atomoxetine
11 Unknown † A Pilot Trial of Homeopathic Treatment for Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Other: Homeopathic Remedies
12 Completed
Has Results 		Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Atomoxetine;   Drug: Placebo
13 Not yet recruiting The Effect of Methylphenidate Versus Placebo on State Anxiety in Children With Attention Deficit Hyperactivity Disorder.
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Methylphenidate
14 Completed A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: methylphenidate hydrochloride extended-release tablets
15 Completed A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity
Intervention: Drug: JNJ-31001074
16 Completed A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity
Intervention: Drug: JNJ-31001074
17 Completed
Has Results 		Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)
Conditions: Attention Deficit Hyperactivity Disorder;   Reading Disorder
Interventions: Drug: Atomoxetine Hydrochloride;   Drug: placebo
18 Completed Influence of Education on Acceptance of Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Among Women
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Behavioral: Education
19 Completed
Has Results 		Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Atomoxetine Hydrochloride;   Drug: Atomoxetine hydrochloride
20 Recruiting Adult Attention Deficit Hyperactivity Disorder
Condition: Adult Attention Deficit Hyperactivity Disorder
Interventions: Drug: SEP-225289;   Drug: Placebo
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years